Home/Filings/4/0001104659-24-109519
4//SEC Filing

Aggarwal Sumit 4

Accession 0001104659-24-109519

CIK 0001035354other

Filed

Oct 16, 8:00 PM ET

Accepted

Oct 17, 4:01 PM ET

Size

5.4 KB

Accession

0001104659-24-109519

Insider Transaction Report

Form 4
Period: 2024-10-16
Transactions
  • Award

    Common Stock

    2024-10-16+165,000169,930 total
Footnotes (1)
  • [F1]This restricted stock award was made under the Issuer's 2018 Equity Incentive Plan and vests as to 25% on October 16, 2025 and in 12 substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.

Issuer

Eloxx Pharmaceuticals, Inc.

CIK 0001035354

Entity typeother

Related Parties

1
  • filerCIK 0001854362

Filing Metadata

Form type
4
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 4:01 PM ET
Size
5.4 KB